A nonbiodegradable scaffold-free cell sheet of genome-engineered mesenchymal stem cells inhibits development of acute kidney injury
- 24 August 2020
- journal article
- research article
- Published by Elsevier BV in Kidney International
- Vol. 99 (1), 117-133
- https://doi.org/10.1016/j.kint.2020.07.043
Abstract
No abstract availableFunding Information
- Novo Nordisk Fonden
- Ministry of Science and ICT, South Korea
- Korea Health Industry Development Institute
This publication has 47 references indexed in Scilit:
- Cellular pathophysiology of ischemic acute kidney injuryJCI Insight, 2011
- Rapid “Open-Source” Engineering of Customized Zinc-Finger Nucleases for Highly Efficient Gene ModificationMolecular Cell, 2008
- Homologous recombination in DNA repair and DNA damage toleranceCell Research, 2008
- The MEK/ERK cascade: From signaling specificity to diverse functionsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- Erythropoietin Decreases Renal Fibrosis in Mice with Ureteral ObstructionJournal of the American Society of Nephrology, 2007
- Mesenchymal Stem Cells in the Wharton's Jelly of the Human Umbilical CordThe International Journal of Cell Cloning, 2004
- Corneal Reconstruction with Tissue-Engineered Cell Sheets Composed of Autologous Oral Mucosal EpitheliumThe New England Journal of Medicine, 2004
- EPO and α-MSH prevent ischemia/reperfusion-induced down-regulation of AQPs and sodium transporters in rat kidneyKidney International, 2004
- Erythropoietin as an antiapoptotic, tissue-protective cytokineCell Death & Differentiation, 2004
- Generation of expression constructs that secrete bioactive αMSH and their use in the treatment of experimental autoimmune encephalomyelitisGene Therapy, 2003